Department of Medical Biochemistry and Microbiology, Uppsala Universitygrid.8993.b, Uppsala, Sweden.
mBio. 2022 Jun 28;13(3):e0144722. doi: 10.1128/mbio.01447-22. Epub 2022 Jun 13.
The use and misuse of antibiotics have resulted in the selection of difficult-to-treat resistant bacteria. Two key parameters that influence the selection of resistant bacteria are the minimal selective concentration (MSC) and the fitness cost of resistance, both of which have been measured during planktonic growth in several studies. However, bacterial growth most often occurs in biofilms, and it is unclear if and how these parameters differ under these two growth conditions. To address this knowledge gap, we compared a selection of several types of antibiotic-resistant Escherichia coli mutants during planktonic and biofilm growth to determine the fitness costs and MSCs. Biofilm-forming Escherichia coli strains are commonly found in catheter-associated and recurrent urinary tract infections. Isogenic strains of a biofilm-forming E. coli strain, differing only in the resistance mechanisms and the fluorescent markers, were constructed, and susceptible and resistant bacteria were grown in head-to-head competitions at various concentrations of antibiotics under planktonic and biofilm conditions. Mutants with resistance to five different antibiotics were studied. The results show that during both planktonic and biofilm growth, selection for the resistant mutants occurred for all antibiotics at sub-MICs far below the MIC of the antibiotic. Even though differences were seen, the MSC values and the fitness costs did not differ systematically between planktonic and biofilm growth, implying that despite the different growth modes, the basic selection parameters are similar. These findings highlight the risk that resistant mutants may, similarly to planktonic growth, also be selected at sub-MICs of antibiotics in biofilms. Our understanding of how and where antibiotic resistance is selected in response to antibiotic exposure is still limited, and this is particularly true for selective processes when bacteria are growing in biofilms, arguably the most significant mode of growth of bacteria in human and animal infections as well as in other settings. In this study, we compared how different types of resistant E. coli strains were selected in response to antibiotic exposure during planktonic and biofilm growth. Determination of the minimal selective concentrations (MSCs) and fitness costs of resistance showed that they were comparable under these two different conditions, even though some differences were observed. Importantly, the MSCs were far below the MICs for all mutants under both planktonic and biofilm growth, emphasizing the significance of low antibiotic concentrations in driving the emergence and enrichment of resistant bacteria.
抗生素的使用和滥用导致了难以治疗的耐药菌的选择。影响耐药菌选择的两个关键参数是最小选择浓度(MSC)和耐药的适应成本,这两个参数在几项研究中都在浮游生长期间进行了测量。然而,细菌的生长通常发生在生物膜中,目前尚不清楚这些参数在这两种生长条件下是否以及如何不同。为了填补这一知识空白,我们比较了几种类型的抗药性大肠杆菌突变体在浮游和生物膜生长过程中的选择,以确定适应成本和 MSC。形成生物膜的大肠杆菌菌株通常存在于导管相关和复发性尿路感染中。构建了一个形成生物膜的大肠杆菌菌株的同基因菌株,仅在耐药机制和荧光标记物上有所不同,并在浮游和生物膜条件下,在各种抗生素浓度下,对头对头竞争中敏感和耐药细菌进行了生长。研究了对五种不同抗生素具有耐药性的突变体。结果表明,在浮游和生物膜生长过程中,所有抗生素在低于抗生素 MIC 的亚 MIC 下都对耐药突变体进行了选择。尽管存在差异,但 MSC 值和适应成本在浮游和生物膜生长之间并没有系统地差异,这意味着尽管生长模式不同,但基本选择参数是相似的。这些发现强调了这样一种风险,即耐药突变体可能与浮游生长一样,在生物膜中抗生素的亚 MIC 下也会被选择。我们对抗生素暴露时抗生素耐药性选择的方式和地点的理解仍然有限,特别是在细菌在生物膜中生长时的选择过程中,这在人类和动物感染以及其他环境中细菌的最重要生长模式中尤其如此。在这项研究中,我们比较了不同类型的抗药性大肠杆菌菌株在浮游和生物膜生长过程中对抗生素暴露的反应是如何被选择的。确定最小选择浓度(MSCs)和耐药的适应成本表明,即使观察到一些差异,它们在这两种不同条件下也是可比的。重要的是,在浮游和生物膜生长下,所有突变体的 MSC 均远低于 MIC,这强调了低抗生素浓度在驱动耐药细菌的出现和富集方面的重要性。